Objective The definition of drug‐resistant epilepsy (DRE) affects case identification and
treatment, and impacts prevalence or incidence estimates and health burden estimation in …

Over the past years, several lines of evidence support a therapeutic potential of Cannabis
derivatives and in particular phytocannabinoids. Δ 9-THC and cannabidiol (CBD) are the …

Objectives To compare the time to treatment failure, remission and first seizure of 12 AEDs
(carbamazepine, phenytoin, sodium valproate, phenobarbitone, oxcarbazepine, lamotrigine …

Purpose: To estimate the burden of lifetime epilepsy (LTE) and active epilepsy (AE) and
examine the influence of study characteristics on prevalence estimates. Methods: We …

Despite the development of new antiepileptic drugs (AEDs),~ 20%–30% of people with
epilepsy remain refractory to treatment and are said to have drug-resistant epilepsy (DRE) …

Partial‐onset epilepsies account for about 60% of all adult epilepsy cases, and temporal
lobe epilepsy (TLE) is the most common type of partial epilepsy referred for epilepsy surgery …

Objective: To estimate the pooled incidence of epilepsy from published studies and
investigate sources of heterogeneity in the estimates. Methods: We searched online …

Epilepsy is a common neurological disease in tropical countries, particularly in sub-Saharan
Africa. Previous work on epilepsy in sub-Saharan Africa has shown that many cases are …

There is geographic variation in the incidence of epileptic syndromes likely to be associated
with genetic and environmental factors, although as yet causality has not been fully …

Purpose: To evaluate the methodology of incidence studies of epilepsy and unprovoked
seizures and to assess the value of their findings by summarizing their results. Methods: A …